Announced the formation of its Clinical Advisory Board. The board will consist of five members and will be chaired by Dr. Robert Gabbay. This globally respected group of experts will provide critical guidance as the company advances clinical development of its Cell Pouch Bio-hybrid Organ with islet cells in patients with T1D. Sernova Biotherapeutics shares T.SVA are trading down $0.01 at $0.22.
Stocks in play: Sernova Biotherapeutics
Baystreet.ca - Baystreet - Contributor Content
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
/Apple%20Inc%20logo%20on%20Apple%20store-by%20PhillDanze%20via%20iStock.jpg)
/Ford%20Motor%20Co_%20logo%20by-%20Vera%20Tikhonova%20via%20iStock.jpg)